KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $758,239 | -40.7% | 35,548 | -60.0% | 0.00% | -50.0% |
Q4 2023 | $1,278,224 | +180.2% | 88,889 | +106.2% | 0.00% | 0.0% |
Q2 2023 | $456,146 | +94.6% | 43,114 | +128.3% | 0.00% | +100.0% |
Q4 2022 | $234,388 | -79.7% | 18,887 | -65.9% | 0.00% | -92.3% |
Q2 2021 | $1,153,000 | +245.2% | 55,307 | +368.6% | 0.01% | +160.0% |
Q1 2021 | $334,000 | +45.2% | 11,802 | +67.7% | 0.01% | +66.7% |
Q4 2020 | $230,000 | -21.5% | 7,038 | -67.0% | 0.00% | -66.7% |
Q4 2019 | $293,000 | – | 21,297 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |